These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34215804)

  • 1. Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties.
    Samarkanova D; Cox S; Hernandez D; Rodriguez L; PĂ©rez ML; Madrigal A; Vilarrodona A; Querol S; Casaroli-Marano RP
    Sci Rep; 2021 Jul; 11(1):13754. PubMed ID: 34215804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord Blood Platelet Rich Plasma Derivatives for Clinical Applications in Non-transfusion Medicine.
    Samarkanova D; Cox S; Hernandez D; Rodriguez L; Casaroli-Marano RP; Madrigal A; Querol S
    Front Immunol; 2020; 11():942. PubMed ID: 32536916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet lysate and chondroitin sulfate loaded contact lenses to heal corneal lesions.
    Sandri G; Bonferoni MC; Rossi S; Delfino A; Riva F; Icaro Cornaglia A; Marrubini G; Musitelli G; Del Fante C; Perotti C; Caramella C; Ferrari F
    Int J Pharm; 2016 Jul; 509(1-2):188-196. PubMed ID: 27234702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment.
    La Gatta A; Corsuto L; Salzillo R; D'Agostino A; De Rosa M; Bracco A; Schiraldi C
    J Ocul Pharmacol Ther; 2018 Dec; 34(10):677-684. PubMed ID: 30325680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activities of an eye drop containing Matricaria chamomilla and Euphrasia officinalis extracts in UVB-induced oxidative stress and inflammation of human corneal cells.
    Bigagli E; Cinci L; D'Ambrosio M; Luceri C
    J Photochem Photobiol B; 2017 Aug; 173():618-625. PubMed ID: 28704790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases.
    Buzzi M; Versura P; Grigolo B; Cavallo C; Terzi A; Pellegrini M; Giannaccare G; Randi V; Campos EC
    Transfus Apher Sci; 2018 Aug; 57(4):549-555. PubMed ID: 29929885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 20% Human Serum on Corneal Epithelial Toxicity Induced by Benzalkonium Chloride: In Vitro and Clinical Studies.
    Moon J; Ko JH; Yoon CH; Kim MK; Oh JY
    Cornea; 2018 May; 37(5):617-623. PubMed ID: 29300263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of allogeneic eye drops from cord blood platelet lysate.
    Samarkanova D; Martin S; Bisbe L; Puig J; Calatayud-Pinuaga M; Rodriguez L; Azqueta C; Coll R; Casaroli-Marano R; Madrigal A; Rebulla P; Querol S;
    Blood Transfus; 2021 Jul; 19(4):347-356. PubMed ID: 33085593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultured corneal epithelia for ocular surface disease.
    Schwab IR
    Trans Am Ophthalmol Soc; 1999; 97():891-986. PubMed ID: 10703147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model.
    Liang H; Baudouin C; Daull P; Garrigue JS; Brignole-Baudouin F
    Mol Vis; 2012; 18():2195-204. PubMed ID: 22919267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Platelet Lysate Compared to Autologous and Allogeneic Serum Eye Drops.
    Zhang J; Crimmins D; Faed JM; Flanagan P; McGhee CNJ; Patel DV
    Transl Vis Sci Technol; 2020 Mar; 9(4):24. PubMed ID: 32818111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the composition of buffered eye-drops prevents undesired side effects.
    Schrage NF; Frentz M; Reim M
    Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical hyaluronan alone promotes corneal epithelial cell migration whereas combination with benzalkonium chloride impairs epithelial wound healing.
    Seino S; Matsuoka R; Masuda Y; Kunou M; Okada Y; Saika S
    Cutan Ocul Toxicol; 2020 Mar; 39(1):13-20. PubMed ID: 31588814
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical Cryopreserved Amniotic Membrane and Umbilical Cord Eye Drops Promote Re-Epithelialization in a Murine Corneal Abrasion Model.
    Tighe S; Moein HR; Chua L; Cheng A; Hamrah P; Tseng SC
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1586-1593. PubMed ID: 28288269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms.
    Geremicca W; Fonte C; Vecchio S
    Blood Transfus; 2010 Apr; 8(2):107-12. PubMed ID: 20383304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.